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Abstract 
Objectives: The systemic environment and satellite 
cell dysfunction have been proposed as important 
contributors in the development of sarcopenia and 
impaired skeletal muscle regrowth with ageing. In 
the present study, we investigated effects of serum 
age on proliferation of muscle precursor cells 
(MPCs) isolated from skeletal muscles of young 
and old rats. 
Materials and methods: We examined proliferation 
and subsequent differentiation of non-passaged 
MPCs isolated from skeletal muscles of 1-, 3- and 
32-month old rats over a 72-h time course, using a 
serum cross-over design. 
Results and conclusions: We found no effect of 
serum age on MPC proliferation, but we did dis- 
cover that MPCs isolated from skeletal muscle of 
32-month old rats had delayed onset of, and exit 
from proliferation, compared to MPCs isolated 
from skeletal muscle of 1-month old rats. Delayed 
proliferation of MPCs from 32-month old rats was 
associated with delayed p38 MAPK 
phosphorylation, and MyoD and p21
Cip1  
protein  
expression. We also demonstrate that MPCs  from  
32-month old rats exhibited lower levels of 
muscle creatine kinase mRNA compared to 1-
month old rats, but elevated levels of myogenin 
mRNA, when stimulated to differentiate after 36 h 
proliferation. These findings suggest that delayed 
entry and exit of the cell 
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cycle observed in MPCs from 32-month old rats 
may compromise their ability to respond to differ- 
entiation stimuli and subsequently impair myogenic 
potential of 32-month old skeletal muscle, in this 
model. 
Introduction 
Ageing is associated with reduced skeletal muscle mass 
and strength, defined as sarcopenia. Sarcopenia can 
result in functional impairment (1,2), physical disability 
(1,3,4) and decreased quality of life (5,6).  Decline in 
capacity to regenerate and repair skeletal muscle may 
contribute to sarcopenia (7,8). Multiple factors [for 
example, satellite cell dysfunction, muscle homeostatic 
niche (myofibres, basal lamina), extracellular matrix, 
microvasculature, neural, immune/inflammatory, fibro- 
adipogenic precursor cells, myokines,  reactive oxygen 
species, energy metabolism, systemic factors and more] 
have been implicated in impaired capacity of aged 
skeletal muscle to regenerate and repair (8,9). The 
multiplicity of factors contributing to sarcopenia makes  
it unlikely that all factors can be considered in a 
single experiment. 
Skeletal muscle cells (fibres) are multinucleate, but 
are terminally differentiated, hence their nuclei are 
unable to replicate (9–11). Satellite cells, a population 
of muscle progenitor cells located outside the fibres yet 
inside the basal lamina, function in repair and growth 
of skeletal muscle through proliferation, fusion into 
existing muscle fibres and differentiation. Some con- 
tend that dysfunctional satellite cells could  negatively 
influence repair and growth, thus contributing to sarco- 
penia. Our current study described here, focuses on 
comparing proliferation and differentiation of satellite 
cells isolated from skeletal muscles of rapidly growing, 
young  (1-  or  3-month  old)  and  old,  sarcopenic  (32- 
month old) rats. 
Sera from young and old animals have been shown 
to differentially alter proliferative phenotypes of their 
(young) and (old) satellite cells. Heterochronic, parabi- 
otic pairings of 2- to 3-month old with 19- to 26-month 
old mice, rescued regeneration in the older individuals 
(12). These authors concluded that age-related decline 
of satellite cell activity could be modulated by systemic 
factors that change with age. Such findings contribute 
to the notion that the systemic milieu plays an impor- 
tant role by altering the stem cell niche or by acting 
directly on the stem cells to suppress regenerative 
potential, in aged skeletal muscle (8). Furthermore, 
Carosio et al. (7) summarized data suggesting that the 
internal systemic environment of a young animal is one 
that promotes successful regeneration, while that of old 
animals either fails to promote, or inhibits, muscle 
regeneration. However, other reports suggest that excep- 
tions to the  above  conclusions  may  occur.  Conboy 
et al. (12) reported that while serum from 2- to 3- 
month old mice enhanced proliferation of satellite cells 
from 19- to 26-month old mice, serum from 19- to 26- 
month old mice did not reduce proliferation of satellite 
cells from 2- to 3-month old mice. George et al. (13) 
reported no effect of age (23- to 36-year old versus 69- 
to 84-year old) of human serum on cultured human 
myoblasts 3, 5 or 7 days after plating, whereas Shav- 
lakadze et al. (14) demonstrated that excellent myotube 
formation occurred on the 10th day after transplantation 
of muscle autografts  from 27- to 29-month old mice, 
into old mice, which they interpreted as meaning that 
myogenic potential had been retained in this sarcopenic 
skeletal muscle. 
One commonality among the above reports is assess- 
ment of either no, or one,  time point within  the first 
48 h after plating satellite cells for culture. We  won- 
dered whether examining a broader time course within 
the first 48 h of plating satellite cells would reveal 
greater insights into satellite cell proliferation. We 
hypothesized that additional time points during the first 
48 h might indicate differences in proliferation between 
satellite cells of young and old rats. Our approach was 
to limit known experimental variables by using a cross- 
over design with heterochronic pairings of young and 
old satellite cells with young and old sera. 
Materials and methods 
Animals 
The  Institutional  Animal  Care  and  Use  Committee  at 
the University of Missouri–Columbia, approved all pro- 
 
cedures of this experiment. 1-, 3- and 32-month old 
Fischer 344 9 Brown Norway F1 hybrid male rats 
were obtained from the National Institute on Aging 
aged rodent colony. These ages were selected for their 
typical growth and skeletal muscle mass characteristics. 
For this study, the 3 animal age groups are defined as 
follows: 
1-month old: rapidly growing 
3-month old: slower growth 
32-month old: growth impairment 
according to growth curves (15) and muscle weights 
(16) previously reported for Fischer 344 9 Brown Nor- 
way F1 hybrid male rats. Animals were housed at 21 ° 
C, 12-h light:dark cycle, and allowed free access to food 
and water. At the time of sacrifice, animals were intra- 
peritoneally injected with ketamine (80 mg/kg), xylazine 
(10 mg/kg) and acepromazine (4 mg/kg), and blood was 
collected by cardiac puncture; then muscles were 
excised. 
Muscle precursor cell isolation procedure 
Muscle precursor cells (MPCs) were isolated from the 
rat skeletal muscle using methods modified as described 
previously (17) at our laboratory (18,19). Briefly, cells 
were isolated from the gastrocnemius and plantaris mus- 
cles of both hind limbs by pronase digestion, and pre- 
plated in Dulbecco's Modified Eagle Medium (DMEM) 
(DMEM;  containing  10%  horse  serum,  100 units/ml 
penicillin, 100 lg/ml streptomycin and 40 lg/ml genta- 
micin) for 2 h, on tissue culture-treated 150-mm plates. 
Due to the small size of 1-month old rats, muscles from 
three animals were combined to make one sample for 1- 
month old MPC isolations. We have previously pub- 
lished that our MPC isolation technique provides greater 
than 90% isolated cells express, thus stain positively, for 
both MyoD and desmin (18–22). 
After 2-h pre-plating, cells were plated on Matrigel 
(BD Biosciences, San Jose, CA, USA)-coated plates 
(0.01 mg/ml Matrigel, 60 min  at  37 °C)  and  cultured 
in  growth  media  (GM;  containing  10%  rat  serum, 
100 units/ml     penicillin,     100 lg/ml     streptomycin, 
40 lg/ml gentamicin in Ham’s F-10) in a humidified 
incubator, 5% O2 and 5% CO2 at 37 °C (HERAcell, 
Thermo Scientific, Waltham, MA, USA). Greater than 
90% of all cells contain desmin- and MyoD-positive 
immunoreactivity (markers for MPCs) using this proto- 
col for MPC isolation (18–22). All experiments in the 
current study were performed on non-passaged (pas- 
sage 0; P-0) MPCs and GM was refreshed every 24 h 
after plating. 
 
 
 
Muscle precursor cell culture experimental design 
Originally, we hypothesized that (i) serum from 32- 
month old rats would attenuate proliferative potential of 
MPCs isolated from skeletal muscle of 3-month old rats 
and (ii) serum from 3-month old rats would enhance 
proliferative potential of MPCs isolated from skeletal 
muscle of 32-month old rats. Thus, serum cross-over 
experiments were performed using P-0 MPCs evenly 
plated across 8 Matrigel-coated 60-mm plates as fol- 
lows: 4 plates 3-month old MPCs cultured in GM con- 
taining 10% rat serum from 3-month old rats (3-month 
old MPC/3-month old GM), and the other 4 plates of 3- 
month old MPCs cultured in GM containing 10% rat 
serum from 32-month old rats (3-month old MPC/32- 
month old GM) and vice versa (n = 4 rats/age group). 
A time-course experiment was performed and MPC pro- 
liferation was analysed at 18, 24, 36 and 48 h after plat- 
ing. Due to non-significant differences in 3-month old 
and 32-month old serum cross-over time-course experi- 
ments, a second serum  cross-over time-course experi- 
ment was performed in the same manner, but with a 
younger set of MPCs (1-month old) and a new set of 32- 
month old MPCs and serum (n = 4–5 rats/age group). 
To analyse MPC proliferation 72 h after plating, the 
original time-course was extended. Thus, MPCs were 
isolated from additional skeletal muscles and cultured in 
GM containing 10% rat serum from the same aged rat 
(that is, 3-month old MPCs cultured in GM containing 
3-month old serum) from 1-, 3- and 32-month old rats, 
to analyse MPC proliferation at 24, 48 and 72 h after 
plating. These data were combined with data for 1-, 3- 
and 32-month old MPCs cultured in GM  containing 
10% rat serum from the same aged rat in the serum 
cross-over experiment described above (n = 4–8 rats/age 
group across all time  points;  except  1-month-old  at 
72 h, n = 1). 
To investigate potential mechanisms responsible for 
observed results in the MPC proliferation time-course 
experiment, MPCs were isolated from new groups of 1- 
and 32-month old animals’ skeletal muscles only (n = 6 
rats/age group), evenly plated on 3–100 mm Matrigel- 
coated plates, and cultured in GM containing 10% rat 
serum (same age as MPCs). MPCs (P-0) were harvested 
at 24, 36 and 48 h after plating and p21
Cip1
, p27
Kip1
, 
MyoD and p38 MAPK proteins, common indices for 
status of the cell cycle, were analysed using western blot 
techniques. 
To determine whether differences in proliferation 
affect ability of 1- and 32-month old MPCs to differenti- 
ate, mRNA levels of muscle creatine kinase and myoge- 
nin, common markers of differentiation status, were 
measured during cell differentiation. MPCs were isolated 
from additional groups of 1- and 32-month old rats 
(n = 4 rats/age group) and plated on 60-mm Matrigel- 
coated plates. To control for potential seeding density 
and proliferation differences between 1- and 32-month 
old P-0 MPCs, cells were plated at fractions of 1/2 (high 
density), 1/3 (medium density) and 1/6 (low density) of 
total cells, with 2 plates per concentration. For each con- 
centration, one plate was harvested and lysed 36 h after 
plating and served as proliferation control, while the 
other was induced to differentiate by replacing GM with 
differentiation medium (DM; 2% rat serum of same age 
as MPCs, in DMEM). Differentiating MPCs were har- 
vested and lysed 24 h after switching to DM. The 36 h 
proliferation time point was chosen based on findings 
from the MPC proliferation time-course experiment. The 
24 h differentiation time point was based on preliminary 
findings that had indicated that 24 h exposure to DM, 
after 36 h proliferation in GM, was sufficient to detect 
increases in muscle creatine kinase mRNA in MPCs, 
isolated from 6-month old rat skeletal muscle (data not 
shown). At the time of harvesting, MPCs were lysed in 
RLT buffer using QIAShredder columns (Qiagen, 
Valencia, CA) according to manufacturer’s specifica- 
tions, and cell lysates were stored at -80 °C until RNA 
isolation. 
Additional 1- and 32-month old MPCs, plated at 
high, medium and low densities, were counted from 
images taken of five random fields of view using light 
microscopy at 49 objective lens magnification. Cell 
counts from the five images were averaged for each 
sample and four independent samples for each age were 
used for statistical analyses. 
 
BrdUrd incorporation 
DNA incorporation of 5-bromo-2′-deoxyuridine 
(BrdUrd) implies that a cell has entered S phase of the 
cell cycle and is actively replicating its DNA (23). Thus, 
incorporation of BrdUrd was measured to be an indica- 
tion of state of MPC proliferation at the time of assess- 
ment (24). MPCs were incubated with 10 lM BrdUrd 
for 60 min before their harvest at designated time points 
after plating. Then they were washed twice in PBS, 
removed from the plates with TrypL Express (Invitro- 
gen, Carlsbad, CA, USA)  and centrifuged  at 500 9 g 
for 5 min, followed by fixing in ice-cold 70% ethanol. 
As previously described (25,26), DNA was denatured 
using  2NHCl  for  30 min,  then  BrdUrd  incorporation 
was detected  using FITC-conjugated  monoclonal anti- 
body raised against BrdUrd (5 lg/ml; Roche Applied 
Sciences,  Indianapolis,  IN,  USA),  in  PBS  with  0.1% 
bovine serum albumin (BSA; Sigma, St. Louis, MO, 
USA).  MPCs  (20 000  cells)  were  analysed  using  a 
 
 
 
FACScan flow cytometer and CellQuest Pro software, 
both from BD Biosciences (San Jose, CA, USA). 
 
Protein sample preparation and western blot analysis 
RNA isolation and real-time PCR 
Total cell RNA was isolated from MPCs using commer- 
cial RNA isolation columns (QIAShredder and RNeasy 
micro  kit)  according  to  manufacturer’s  specifications. 
Total cell protein was isolated from MPCs at designated RNA was quantified using a NanoDrop
®
 1000 spectro- 
time points after plating, as described above. Cells were 
lysed using RIPA buffer with protease inhibitor (P8340; 
Sigma, St. Louis, MO, USA) and phosphatase inhibitor 
(P2850 and P5726; Sigma) cocktails. Cell lysates were 
incubated on ice for 30 min and then insoluble protein 
fraction was cleared by centrifugation at 12 000 9 g for 
20 min at 4 °C. Cell lysates were stored at -80 °C until 
further processing. Due to large buffer volume required 
to harvest and lyse the MPCs, cell lysates were concen- 
trated using Amicon Ultra-0.5 ml centrifugal filters (Mil- 
lipore, Billerica, MA, USA) then protein content  for 
each sample was determined using bicinchoninic acid 
(BCA Protein assay kit; Pierce, Rockford, IL, USA). 
Expressions  of  cell  cycle  inhibitors,  p21
Cip1    
and 
p27
Kip1
, phosphorylated p38 MAPK and MyoD protein 
were analysed by standard Western blotting techniques. 
Protein cell lysates were diluted to 0.4 lg/lL in Lae- 
mmli buffer, boiled for 5 min and 30 ll (12 lg total) 
protein sample was separated by SDS-PAGE on 12% 
gels. Proteins were transferred to nitrocellulose 
membranes and stained with Ponceau S. To ensure equal 
protein loading across the lanes, images of Ponceau S-
stained membranes were acquired using a flatbed 
scanner (Epson 3170 Photo Scanner; Epson America, 
Inc., Long Beach, CA, USA) and optical density of lane 
length was quantified using Kodak molecular imaging 
software (version 4.0; Eastman Kodak Company, 
Rochester, NY, USA); there were no significant differ- 
ences in protein quantities across membranes (data not 
shown). Membranes were blocked in 5% non-fat  dry 
milk (NFDM) for 1 h at room temperature and then 
incubated with primary antibody overnight at 4 °C. Pri- 
mary antibodies were used in the following conditions: 
p21
Cip1 
(Millipore, Billerica, MA, USA) 1:200 dilution 
in 5% NFDM; p27
Kip1 
(Santa Cruz Biotechnology, 
Santa Cruz, CA, USA) 1:200 in 5% NFDM; phospho- 
p38 MAPK (Cell Signaling, Danvers,  MA,  USA) 
1:1000 dilution in 5% BSA and MyoD (Santa Cruz 
Biotechnology) 1:500 dilution in 5% NFDM. Immuno- 
blots were incubated with ImmunoPure
® 
peroxidase- 
conjugated secondary antibody (Pierce; 1:1000 dilution 
in 5% NFDM) for 1 h at room temperature. Antibody 
complexes were detected using SuperSignal
® 
WestDura 
Western Blotting  Detection reagent  (Pierce)  and a 
Kodak Image  Station 4000R  Digital Imaging System. 
Immunoblots were quantified using Kodak molecular 
imaging software. 
photometer (Thermo Scientific) and stored at -80 °C 
until reverse transcription. RNA purity was verified by 
260:280 ratios 2:1.8 (data not shown). Reverse transcrip- 
tion was performed on equal amounts of total RNA 
sample using High Capacity cDNA Reverse Transcrip- 
tion kit [Applied Biosystems (AB), Foster City, CA]. 
Muscle creatine kinase (MCK) and myogenin mRNA 
levels were determined using quantitative real-time PCR 
and reactions, performed in duplicate with SYBRGreen 
PCR master mix (AB), contained 25 ng cDNA and 
900 nM each forward and reverse primers in 25 ll vol- 
ume. An AB Prism 7000 sequence detection system was 
used for all real-time PCR reactions. Real-time PCR 
primers were designed with Primer Express 2.0 (AB) 
using specific BLAST sequences for rat genes. Informa- 
tion on primer sequences used for mRNA templates is 
provided in Table 1. All primers were validated and 
amplification efficiency was verified prior to experimen- 
tation (data not shown). Amplicon product size was con- 
firmed by gel electrophoresis using 3.0% agarose gel 
stained by ethidium bromide and visualized using ultra- 
violet light (data not shown). Dissociation (melting) 
curves after SYBRGreen real-time PCR also served as 
validation for specific product amplification (data not 
shown). Relative changes in mRNA levels were deter- 
mined using the DDCt method (AB User Bulletin no. 2) 
and normalized to 18SrRNA. Levels of 18S rRNA were 
unchanged over the various time points or between pro- 
liferating and differentiating MPCs (data not shown). 
 
 
Statistical analyses 
BrdUrd incorporation data from the two serum cross- 
over proliferation time-course experiments (3- versus 
32-month old, Fig. 1 and 1- versus  32-month  old, 
Fig. 2) were  analysed   using  three-way  ANOVA 
(serum 9 age 9 time). BrdUrd incorporation data from 
the proliferation time-course experiment comparing all 
three age groups in the same aged serum (1- versus 3- 
versus 32-month old, Fig. 3), as well as phosphorylated 
p38 MAPK, MyoD, p21 and p27 protein levels (Fig. 4), 
were analysed using two-way repeated measures ANO- 
VA (age 9 time). A one-way ANOVA was performed 
on the area beneath the curve (AUC) data from the pro- 
liferation time-course experiment, comparing the three 
different ages. Following significant F-ratios with 
ANOVA analyses, Holm-Sidak or Fisher LSD post-hoc 
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Table 1. Primer sequences used for SYBR Green real-time PCR quantification of target RNA 
 
Target Forward primer Reverse primer 
Muscle creatine kinase 
Myogenin 
18S 
GACCACCTTCGCGTGATCTC 
GCCCCTGAGTTGGTGTCAGA 
GCCGCTAGAGGTGAAATTCTTG 
CGGCGGAAAACTTCCTTCA 
AGGACAGCCCCACTTAAAAGG 
CATTCTTGGCAAAGCTTTCG 
 
 
 
3-month MPC/3-month serum 
3-month MPC/32-month serum 
32-month MPC/32-month serum 
32-month MPC/3-month serum 
80 
 
1-month MPC/1-month serum 
1-month MPC/32-month serum 
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Figure 1. Three- and 32-month old P-0 MPCs in serum cross-over 
time-course experiment. P-0 MPCs isolated from 3- and 32-month 
old rat skeletal muscles were analysed for BrdUrd incorporation (as an 
index of proliferation) in a serum cross-over design. There was a sig- 
nificant main effect of age on BrdUrd incorporation. However, treat- 
ment of MPCs with different aged serum tended to be  significant 
across the time course of BrdUrd incorporation (P = 0.094). *indicates 
significant difference from 32-month old MPCs at the same time point. 
Data presented as Mean ± SEM; n = 4 rats/each. 
 
Figure 2. One- and 32-month old P-0 MPCs in serum cross-over 
time-course experiment. P-0 MPCs isolated from 1- and 32-month 
old rat skeletal muscles were analysed for BrdUrd incorporation (as an 
indicator of proliferation) in a serum cross-over design. There was a 
significant main effect of age on BrdUrd incorporation; however, there 
was no effect of treatment with different aged sera across the time 
course (P = 0.344).*indicates significantly different from 32-month old 
MPCs at the same time point. Data presented as Mean ± SEM; n = 4- 
5 rats/each. 
 
analyses were performed to determine differences 
between groups. Student’s unpaired t-tests were per- 
formed on cell density data (Table 2), as well as relative 
quantification data (using the DDCT method) on MCK 
and myogenin mRNA levels from the differentiation 
experiments (Fig. 5). Statistical significance was set at 
P ::; 0.05; all data are presented as mean ± SEM. 
 
Results 
 
Serum cross-over experiments 
Previous reports have obtained mixed results for 
responses in MPC proliferation in cross-over studies 
using sera from young and old animals with MPCs from 
 
young or old skeletal muscle (12–14,27). Common to 
these studies is the investigation of no early time point 
or only a single time point within the first 48 h of plat- 
ing. We deduced that examining multiple time points 
within 48 h of plating P-0 MPCs might reveal resolution 
absent in previous reports. The initial objective of this 
study was to determine whether (i) serum from 32- 
month old rats would reduce proliferative potential of 
MPCs from 3-month old animals; and (ii) serum from 
3-month old rats would increase proliferative potential 
of MPCs from 32-month old rats. Using BrdUrd 
incorporation as an index of the state of MPC 
proliferation, P-0 MPCs were isolated from 3-month 
old and 32- month old rat skeletal muscles and allowed 
to proliferate for up to 48 h in GM containing either 
serum from the 
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Figure 3. Expanded proliferation time course of 1-, 3- and 32- 
month old P-0 MPCs. The proliferation BrdUrd incorporation time- 
course data with 1-, 3- and 32-month old P-0 MPCs exposed only to 
media containing serum from same aged rats (1-mo MPCs with 1-mo 
serum, etc.) were combined and expanded to include more animals and 
a 72-h time point. BrdUrd incorporation of 1-month old MPCs peaked 
at the 24-h time point and was significantly higher than 3- and 32- 
month old MPCs. However, BrdUrd incorporation in 1-month old 
MPCs returned to baseline by 48 h. On the other hand, proliferation of 
MPCs from 3- and 32-month old skeletal muscles peaked at 36 h; and 
while 3-month old MPC proliferation started to decline at 48 h, 
BrdUrd incorporation in 32-month  old  MPC  remained  elevated  at 
48 h. BrdUrd incorporation in MPCs of all ages returned to baseline 
by 72h. Significant differences within the same time point are indicated 
by different letters. Data presented as Mean ± SEM; n = 4–8  rats/ 
each, except for 1-month-old MPC at 72 h (n = 1 rat). 
 
 
same aged rat or different aged rat serum (Fig. 1). There 
was a significant main effect of age on BrdUrd incorpo- 
ration; however, treatment of MPCs with different aged 
serum only tended towards significance across the time 
course of BrdUrd incorporation (P = 0.094). The 
BrdUrd incorporation was significantly higher in 3- 
month old MPCs at 24 h, but lower at 48 h, compared 
with 32-month old MPCs at those same time points. 
There was no difference in BrdUrd incorporation 
between 3- and 32-month old MPCs at 18 and 36 h 
Importantly, our results revealed peak values for BrdUrd 
incorporation of~60% of nuclei at 24 and 36 h for MPCs 
plated from 3-month old rats, but with peak BrdUrd 
incorporation delayed to 36 and 48 h for MPCs from 
32-month old animals. This observation, along with the 
fact that 3-month old rats have lower percentage daily 
growth than 1-month old ones (28), led us to think that 
1-month old MPCs may show even greater age differ- 
ences in peak BrdUrd incorporation, compared to 32- 
month old MPCs. 
Thus, the proliferation time-course serum cross-over 
experiment was repeated; however, this time 1- and 32-
month old rats were used. As in Fig. 1, no  treatment 
effect of serum age was observed across the time- 
course (P = 0.344). Importantly, however, times of 
peak BrdUrd incorporation into P-0 MPCs for 1-month 
old versus 32-month old serum cross-over experiment 
(Fig. 2) differed from peak times in our previous exper- 
iment (Fig. 1) using MPCs from 3- and 32-month old 
skeletal muscles. Again, as with the 3- and 32-month 
old comparisons, a significant  main  effect  of  age 
existed for BrdUrd incorporation between the 1- and 32-
month old MPCs. BrdUrd incorporation was higher in 
1-month old MPCs at 24 h, but lower at the 36- and 
48-h time points, compared to 32-month old MPCs. 
There was no difference in BrdUrd incorporation 
between 1- and 32-month old MPCs at 18 h. 
Comparisons between Figs 1 and 2 led to two new  
observations: (i) at the time point of 36 h post-plating, 
no difference existed between 3- and 32-month old 
MPCs (Fig. 1), but significantly lower BrdUrd 
incorporation was  present  in  1-month  old  than  in  
32-month  old 
MPCs at this 36-h time point (Fig. 2); and (ii) at the 
time point of 48 h post-plating, ~60% of nuclei were 
BrdUrd-labelled in 32-month old cells, but only about 
~15% of nuclei were labelled in 1-month old MPCs, 
which is essentially baseline labelling.  These  findings 
led to the question: Did 32-month old MPCs return to 
baseline at 72 h post-plating? 
 
Expanded MPC proliferation time-course 
Proliferation time-course experiment with  P-0  MPCs 
was expanded to include a 72-h time point and to 
include all three ages of MPCs from 1-month old, 3- 
month old and 32-month old skeletal muscles (plated in 
GM containing serum from the same aged rats, that is, 
1-month old MPCs with 1-month old serum,  and  so 
on.). Combined data were analysed and plotted as seen 
in Fig. 3. Statistical analyses revealed significant overall 
interaction (P < 0.001) in proliferation among 1-, 3- and 
32-month old MPCs. Interestingly, BrdUrd incorporation 
in 1-month old MPCs peaked at the 24-hr time point 
and was significantly higher than 3- and 32-month old 
MPCs; however, BrdUrd incorporation in 1-month old 
MPCs began to decline at 36 h and returned to baseline 
by 48 h. On the other hand, BrdUrd incorporation in 3- 
and 32-month old MPCs peaked at 36 h, while BrdUrd 
incorporation in 3-month old MPC started to decline at 
48 h, 32-month old MPC BrdUrd  incorporation 
remained elevated at 48 h. MPC BrdUrd incorporation 
at all ages returned to baseline by the 72-h time point. 
While  it  appears  that  1-month  old  MPCs  displayed 
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Figure 4. Time course of phosphorylated p38, MyoD, p21 and p27 protein expression. Phosphorylated p38 (A), MyoD (B) and cell cycle 
inhibitors, p21 (C) and p27 (D), were analysed at 24 (opens bars), 36 (hatched bars) and 48 (filled bars) hours in proliferating 1- and 32-month old 
P-0 MPCs exposed only to media containing serum from the same aged rats (1-month old MPCs with 1-month old serum, etc.). (a) Increased p38 
phosphorylation was delayed in 32-month old MPCs, compared to 1-month old MPCs. (b) MyoD protein expression increased in 1-month old 
MPCs at 36 and 48 h, compared to 24 h, but not in 32-month old MPCs. (c) p21 protein expression significantly increased in 1-month old MPCs 
at 48 h, but not in 32-month old MPCs. D) p27 protein expression was significantly higher at 48 h (main effect of time). *indicating significant dif- 
ference from 24 h within the same age group; #indicates significant difference from 1-month old MPCs within the same time point. Images of rep- 
resentative immunoblots are placed above each protein target.  Densitometry  data  are  presented  as  arbitrary  units  (AU)  and  displayed  as 
Mean ± SEM. n = 6/each for p38; n = 5/each for MyoD and p27; n = 3/each for p21. 
 
 
higher BrdUrd incorporation early in the  time  course 
and 32-month old MPCs displayed higher BrdUrd incor- 
poration later in the time course, when areas under the 
curve (AUC) were analysed, 32-month old MPC BrdUrd 
incorporation AUC was significantly greater than that of 
1-month old MPCs. Taken together, these data suggest 
that in this model of P-0 MPCs isolated from 1-, 3- and 
32-month old skeletal muscles and plated in GM con- 
taining the same aged serum, younger MPCs began to 
increase BrdUrd incorporation earlier after plating than 
32-month old MPCs, while 32-month old MPCs had a 
more prolonged BrdUrd incorporation period than young 
MPCs during the same time-course. Furthermore, 1- 
month old MPCs appeared to withdraw from the cell 
cycle earlier than 32-month old MPCs. As withdrawal 
from proliferation is required to begin  differentiation 
and BrdUrd incorporation was 10–15% at 48 h post- 
plating in 1-month old MPCs, but nearly 60% at 48 h in 
32-month old MPCs, we next examined markers for the 
cell cycle and for differentiation, with the generated 
hypothesis that these markers would associate with 
differences in BrdUrd incorporation between 1-month 
old and 32-month old MPCs. 
 
Muscle-specific regulatory factors and cell cycle 
inhibitors in proliferating MPCs 
To investigate potential mechanisms explaining differ- 
ences in BrdUrd incorporation between 1- and 32- 
month old MPCs observed in the expanded MPC pro- 
liferation time-course experiment, MPCs were isolated 
from 1-month old and 32-month old rat skeletal mus- 
cles, plated in  GM  containing  the  same  aged  serum 
as MPCs and harvested at 24, 36 or 48 h, for deter- 
mination of p38 MAPK phosphorylation and protein 
expression of MyoD and cell cycle inhibitors.  These 
time points were chosen as peak BrdUrd incorporation 
values for both 1-month old and 32-month old MPCs 
were contained over  this time  frame.  Phosphorylation 
of p38 MAPK was significantly elevated at 36 h  and 
tended to remain high at 48 h (P = 0.099) in 1-month 
old MPCs. However, p38 MAPK phosphorylation was 
p
h
o
s
p
h
o
ry
la
te
d
 
p
3
8
 P
ro
te
in
 (
A
U
) 
M
y
o
D
 P
ro
te
in
 (
A
U
) 
p
2
1
 P
ro
te
in
 (
A
U
) 
p
2
7
 P
ro
te
in
 (
A
U
) 
 
 
1-month 
32-month 
* 
* 
MCK Myogenin 
 
A 
600 
 
500 
 
400 
 
300 
 
200 
 
100 
 
0 
 
 
B 
 
1-month 32-month 
 
Figure 5. Muscle creatine kinase (MCK) and myogenin mRNA in 
differentiating MPCs. (a) MCK and Myogenin mRNA levels were 
measured as markers of differentiation in 1-month old (opens bars) and 
32-month old (filled bars) P-0 MPCs after 36 h proliferation (control) 
and 24 h reduced serum conditions (differentiation). MCK mRNA was 
significantly higher in 1-month old MPCs after 24 h differentiation 
compared to 32-month old MPCs. However, myogenin mRNA was 
substantially higher in 32-month old MPCs compared to 1-month old 
MPCs.  *indicates  significant  difference  from  1-mo  MPCs.  Relative 
quantification data (DDCT  method) were normalized to 18S rRNA and 
are  presented  as  fold  change  from  control,  and  displayed   as 
Mean ± SEM. n = 4 rats/each. (b) Representative light micrographs of 
1- and 32-mo MPCs (seeded at medium density) after 24 h exposure 
to differentiation conditions. Cultures from 1-month old MPCs appear 
to have more fused cells after 24 h differentiation compared to 32- 
month old MPCs at the same time point. Scale bar = 100 lm. 
 
 
delayed and not significantly raised until the  48-h 
time point in 32-month old MPCs (Fig. 4a). In 1- 
month old MPCs, MyoD protein expression increased 
nearly 3- and 5-fold at 36 and 48 h, respectively, 
compared with 24 h. More importantly, MyoD was 
significantly higher in 1-month  old  MPCs  at  36  and 
48 h, compared to 32-month  old  MPCs,  but  not  at 
24 h (Fig. 4b). 
Cell cycle inhibitors, p21
Cip1  
and p27
Kip1
, were also 
analyzed to determine whether their expression would 
be altered during the proliferation time-courses of 1- 
month old and 32-month old MPCs. In 1-month old 
MPCs, p21
Cip1 
protein increased at 48 h compared to 24 
and 36 h, while no increase in p21
Cip1 
protein was 
observed in 32-month old MPCs (Fig. 4c). More impor- 
tantly,   p21
Cip1     
protein   was   significantly   higher   in 
1-month old MPCs at 48 h compared to 32-month old 
MPCs at the same time point. On the other hand, there 
was no effect of age on p27
Kip1 
protein expression 
during the time course of proliferation, thus we did not 
make associations between p27 expression and 
proliferation indices over this time period. However, 
there was a significant main effect of time in 
expression of p27
Kip1 
(Fig. 4d), where p27
Kip1 
protein 
was higher at the 48-h time point, compared to 24 
and 36 h. Taken together, these data suggest that 
increased p38 MAPK phosphorylation and MyoD and 
p21
Cip1 
protein expression might play a role in early 
withdrawal from the cell cycle of 1- month old MPCs. 
Likewise, delayed phosphorylation of p38 MAPK and 
lower expression of MyoD and p21
Cip1 
at the 48-h 
time point may explain why 32-month old MPCs 
displayed prolonged BrdUrd incorporation period and 
delayed exit from the cell cycle compared to 1- month 
old MPCs. 
 
Markers of differentiation in MPCs from skeletal 
muscles of 1- and 32-month old rats 
To determine whether differences in timing of cell cycle 
withdrawal from proliferation would alter induction of 
differentiation, levels of MCK and myogenin mRNA 
(markers of differentiation) were measured in 1- and 32- 
month old MPCs after 24 h exposure to differentiation 
media. To  control for  differences in proliferation and 
cell density, P-0 MPCs were plated at high, medium and 
low densities, allowed to proliferate for 36 h, then 
switched to differentiation media; cells were harvested 
after 24 h in differentiation conditions. 
To test for which age group would progress most 
towards differentiation, prior to full differentiation and 
fusion into myotubes, MCK mRNA levels were found 
to be significantly higher  in  1-month  old  MPCs after 
24 h differentiation compared to 32-month old MPCs, 
regardless of the three cell plating densities. Data from 
medium density MPC cultures are displayed in Fig. 5a 
(data from high densities and low densities not shown, 
but results were similar to medium-density MPC 
cultures). On the contrary, myogenin mRNA levels 
were substantially higher in 32-month old MPCs at any 
den- sity compared to 1-month old MPCs. Figure 5b 
shows representative images from 1- and 32-month old 
MPCs seeded at medium density after 24 h in 
differentiation media. In addition, cells were counted 
from high-, medium- and low-density cultures after 36 h 
proliferation (immediately before switching to 
differentiation media). While not significant, cell counts 
from all 3 densities of 1-month old MPC cultures 
tended to be higher  than those of 32-month old MPC 
cultures at that time point of proliferation (Table 2). 
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Table 2. Cell counts of 1- and 32-month-old P-0 MPCs that were pla- 
ted at high (1/2 of the cells), medium (1/3) and low (1/6) densities and 
then allowed to proliferate for 36 h. Cell counts were performed from 
images taken using light microscopy (49 objective) on at least five 
random fields of view across the plate; fields of view must have con- 
tained at least 50 cells/cm2 to be counted. n = 4 rats for each density/ 
age group 
cell cycle, observed in 32-month old MPCs may com- 
promise their ability to respond within a given narrow 
time window to initiate differentiation, and thus subse- 
quently impairing myogenic potential of old, sarcopenic 
skeletal muscle to support regeneration  or  muscle 
growth from atrophy. 
 
 
 
Plating 
density 
1-month-old 
MPC (cells/cm2 
± SEM) 
32-month-old 
MPC (cells/cm2 
± SEM) P-value 
 
Delayed entry into and exit from the cell cycle in MPCs 
from skeletal muscle of 32-month old rats 
High 433 ± 91 227 ± 31 0.075 
Medium 252 ± 52 135 ± 18 0.079 
Low 121 ± 20 69 ± 12 0.065 
 
 
 
 
Discussion 
Several mechanisms, including satellite cell dysfunction, 
have been proposed to contribute to sarcopenia and 
impaired regrowth and regeneration observed in skeletal 
muscle with ageing (9–11). Satellite cells serve as a 
source of new myonuclei during muscle repair and 
growth because existing myonuclei are believed to have 
permanently withdrawn from the cell cycle. While dis- 
crepancies exist in the literature regarding whether sys- 
temic factors modulate satellite cell function  with 
ageing, few studies have examined this with more than 
a single time point within 48 h of plating of non-pas- 
saged (P-0) MPCs, a time period when early phase 
events occur during in vivo muscle regeneration (29). In 
the present study, we have examined BrdUrd incorpora- 
tion, and subsequent differentiation, of P-0 MPCs iso- 
lated from rapidly growing (1-month old) and growth- 
impaired, atrophying, sarcopenic, rat skeletal muscle 
(32-month old), over an acute time-course with multiple 
time points (18–72 h after plating), using a serum cross- 
over design cell culture model. The main findings of this 
study were: (i) No effect of serum age on MPC BrdUrd 
incorporation; (ii) Delayed onset of, and exit from, pro- 
liferation of MPCs isolated from 32-month old skeletal 
muscle compared to MPCs isolated from 1-month old 
skeletal muscle; (iii) Differences in BrdUrd incorpora- 
tion among 1-month old, 3-month old and 32-month old 
individuals at given culture time points were associated 
with differences in p38 MAPK phosphorylation, as well 
as MyoD and p21
Cip1 
protein expression; and (iv) 
Reduced levels of MCK mRNA (indication of reduced 
differentiation potential) in MPCs isolated from 32- 
month old skeletal muscle compared to MPCs isolated 
from 1-month old skeletal muscle, after 1-month old and 
32-month old MPCs were subjected to differentiation 
conditions at the 36th hour post-plating. Taken together, 
we postulate that delayed entry into and exit from the 
While the results from our serum cross-over experiments 
suggest that there is no extrinsic effect of serum age on 
BrdUrd incorporation in P-0 MPCs from skeletal mus- 
cles of 1-, 3- and 32-month old rats, distinct differences 
were evident in BrdUrd incorporation between these 
three ages. The results are unique due to our inclusion 
of 1-month old MPCs. We added the 1-month old cate- 
gory only after our initial investigation of groups at 3 or 
32 month  of  age.  The   near   similarity   of   3-   and 
32 month old MPCs for peak BrdUrd incorporation after 
plating (Fig. 1) led us to question whether this similarity 
might be related to their both having relatively low per- 
centages of daily changes in muscle mass. One-month 
old rats have higher percentage enlargement in skeletal 
muscle mass than 3-month old and 32-month old rats. 
Indeed, addition of the 1-month old rapid growth group 
revealed an earlier peak proliferation after plating MPCs 
than for growth-impaired, atrophying, sarcopenic 32- 
month old rats (Fig. 2), as described in more detail 
below. 
Cells of all three age groups remained relatively 
inactive 18 h after plating in growth media (Fig. 3), as 
predicted from earlier reports (30). Assuming that the 
isolation process activates the MPCs to enter the cell 
cycle and begin proliferation (31), we observed a fairly 
synchronous and rapid entry into cell cycle in 1- and 3- 
month old MPCs 24 h after plating; however, entry into 
the cell cycle in 32-month old MPCs was started later. 
In addition, the time-course of BrdUrd incorporation in 
the current study from 1-month old MPCs was signifi- 
cantly shorter than that of 3- and 32-month old MPCs. 
After BrdUrd incorporation, 1-month old MPCs peaked 
at 24 h, and rapidly returned baseline levels by 48 h. 
However, BrdUrd incorporation in 3- and 32-month old 
MPCs remained high at 36 h and  then  gradually 
returned to baseline by 72 h. The shorter proliferative 
period we observed in 1-month old MPCs is similar to 
that reported in young animals in vivo by Schultz (23) 
and in vitro by Barani et al. (30), but our observations 
in 32-month old MPCs are opposite to those of Barani 
et al. (30), who reported a 28-hour proliferative period 
at the 7th day post-plating of muscle-derived cells from 
24-month-old rats. 
 
 
 
More recently, Lavasani et al. (32) demonstrated that 
muscle-derived stem cells isolated from young mice 
secrete factors that enhance proliferation and myogenic 
differentiation of muscle-derived stem cells from old 
skeletal muscle in a transwell insert co-culture system. 
However, these studies were executed over a much 
longer time frame than the current study, in cells that 
were passaged. Furthermore, Schultz and Lipton (33) 
examined numbers of progeny in vitro from  satellite 
cells isolated from 6 days to 30 months of age and dis- 
covered that cells from 6- to 30-day old muscles repli- 
cated strikingly faster than cells from 3- to 30-month 
old muscles. These authors concluded that numbers of 
satellite cell progeny are inversely proportional to age, 
and suggested that there is clear delineation in satellite 
cell growth between rapidly growing and sarcopenic 
muscles. To the best of our knowledge, our study is the 
first to demonstrate differences in proliferation of non- 
passage MPCs isolated from very young, rapidly grow- 
ing (1-month old) and growth-impaired, atrophying, 
sarcopenic (32-month old) skeletal muscles, of a time 
course within 72 h of plating. 
Progressive delay in the time to peak BrdUrd incor- 
poration after plating and its prolonged time to return to 
baseline for cultured non-passaged MPCs from 32- 
month old skeletal muscle, relative to 1-month old, dem- 
onstrates a direct relationship to age of animal, and 
inverse relationship to percentage increases in growth 
frequencies of muscle mass. For example, the longest 
time to peak BrdUrd incorporation and consequent 
return to relative baseline, was in MPCs from 32-month 
old skeletal muscle (Table 3). On the other hand, the 
shortest time to peak BrdUrd incorporation, followed by 
return to relative baseline was in MPCs from 1-month 
old skeletal muscle. Patterns for BrdUrd incorporation 
over the time-course were more comparable between 3- 
month old and 32-month old MPCs after plating than to 
1-month old MPCs, suggesting importance of the envi- 
ronment of rapid growth status in skeletal muscle from 
which  satellite  cells  were  isolated.  These  associations 
led to two additional questions: (i) What changes in 
myogenic and cell cycle regulatory proteins might 
account for delays in proliferation?; and (ii) Was 
delayed proliferation associated with impaired differenti- 
ation of old satellite cells? 
To address the first question, we examined differ- 
ent myogenic regulatory factors (MRFs) related to cell 
cycle progression and withdrawal. As myoblasts with- 
draw from the cell cycle and commit to differentiation, 
there is timely coordination of intracellular signalling 
with a number of MRFs (Myf5, MyoD, myogenin and 
MRF4) that regulate different myogenic events during 
differentiation. p38 MAPK plays a critical role in the 
ability of myoblasts to exit the cell cycle and differen- 
tiate (31). Activation of p38 MAPK is critical for 
muscle cells to express MyoD  (34);  further  p38 
MAPK activation also serves to guarantee  complex 
and timely activation of muscle differentiation (34). 
Here, for the first time, under our experimental condi- 
tions, we report the novel finding that delayed p38 
MAPK activation is associated with delayed expression 
of MyoD protein in 32-month old MPCs, compared to 
1-month old MPCs. 
Cyclin-dependent kinase inhibitors, p21
Cip1 
and 
p27
Kip1
, play a critical role in regulation of cell cycle 
progression through the  G1-S checkpoint. It has been 
suggested that p27
Kip1 
acts as the trigger to initiate 
myoblast exit from the cell cycle, while p21
Cip1 
maintains cell cycle arrest and progression to a post-
mitotic state, and subsequent differentiation (35). 
Inhibiting p27
Kip1 
and p21
Cip1 
expression prevents the 
ability of myoblasts to withdraw from the cell cycle 
(36) and overexpression 
of them induces G1 cell cycle arrest (37). Furthermore, 
upregulation of MyoD induces blockade of cell cycle 
progression, as shown by the ability of MyoD to induce 
p21
Cip1 
expression (38). It has been reported that MyoD 
protein in satellite cells from old skeletal muscle is 
higher (39), lower (40) or is the same (10) compared to 
young. Despite discrepancies between relative expression 
of MyoD of young and old satellite cells, MyoD is 
 
 
Table 3. Associations of age, changes in skeletal muscle mass, characteristics of satellite cell proliferation, peak BrdUrd incorporation and return 
of BrdUrd incorporation to baseline (taken from Fig. 3) 
 
 Plating time for  
 Changes in growth 
and skeletal muscle 
Characteristics of 
satellite cell 
 
Peak BrdUrd 
Return to 
baseline BrdUrd 
Age mass proliferation incorporation incorporation 
1-month Rapid growth Active 24 h 48 h 
3-month Slower growth Relatively quiescent 24–36 h 72 h 
32-month Sarcopenic atrophy Quiescent 36–48 h 72 h 
 
 
 
required for differentiation of myogenic cells (41,42). 
Our results show that p21
Cip1 
protein was lower in the 
32-month old MPCs compared to 1-month olds at the 
48-h time point. Interestingly, p21
Cip1 
protein levels 
appear to be inversely proportional to proliferation at the 
same time point during the time-course, suggesting that 
lower p21
Cip1 
expression may play a role in delayed exit 
from the cell cycle observed in 32-month old MPCs. 
Taken together, these observations suggest that 
delayed p38 MAPK activation in MPCs from non-trea- 
ted muscles leads to delayed MyoD and p21
Cip1 
protein 
expression, thus impairing the ability of MPCs from 32- 
month old skeletal muscle to withdraw from the cell 
cycle. Based on studies in skeletal muscle regeneration, 
satellite cells are first activated to proliferate, then are 
induced to differentiate and fuse to regenerate myofi- 
bres. Signals that stimulate proliferation and induce dif- 
ferentiation of satellite cells, while not yet fully 
identified, are thought to be mutually exclusive (43). It 
is well known, however, that exit from the cell cycle is 
prerequisite to terminal differentiation and fusion of 
satellite cells (44). The time-course utilized in the cur- 
rent study and progression of signalling events observed 
during proliferation and exit from the cell cycle, are 
consistent with timing of early phase events that occur 
during muscle regeneration in vivo (29). Thus, we 
hypothesize  that  if  the  phenomenon  of  delayed  MPC 
exit from the cell cycle pre-existed in old skeletal mus- 
cle in response to a myogenic stimulus (regeneration, 
impaired regrowth from atrophy and so on), responsive- 
ness of old MPCs might be too slow to activate and thus 
miss that window for differentiation, resulting in impaired/ 
incomplete muscle regeneration. While limited data sup- 
port such a concept, Schuierer et al. (45) speculate that if 
reduced rates of differentiation were to occur in vivo, this 
could have serious consequences for muscle repair. 
 
Reduced markers of differentiation in MPCs from old 
skeletal muscle 
Given that exit from the cell cycle is required for myo- 
blasts to differentiate and fuse into myofibres (44), we 
questioned whether delay in cell cycle exit observed in 
32-month old MPCs was associated with less potential 
for differentiation. Thus, we employed a unique 
experimental design where P-0 MPCs were plated after 
isolation (as with the proliferation time-course 
experiments), allowed to proliferate for 36 h, and 
then were experimentally induced to differentiate. 
MPCs were allowed to differentiate for only 24 h 
from the 36th hour, and then cells were harvested and 
myogenic factors involved in differentiation were 
analysed. The 36-h proliferation time point was 
chosen as it represents a time, in our 
model, where 1-month old MPCs have lower prolifera- 
tion by approximately one-half and 32-month old MPCs 
have just peaked proliferating. Furthermore, the time of 
24 h differentiation was selected as it was  sufficient 
time to detect early events of differentiation, but cells 
had not yet fully fused into multinucleate myotubes. As 
expected, 32-month old MPCs displayed lower MCK 
mRNA after 24 h differentiation compared to 1-month 
old MPCs. Myogenin is an important MRF  that  can 
bind to E-box sequences to promote expression of sev- 
eral muscle-specific genes, such as MCK (46); however, 
increased myogenin expression and promotion of MCK 
expression, based on our observation of substantially 
higher levels of myogenin mRNA in differentiating 
MPCs from old skeletal muscle, appear to be discon- 
nected. These findings are consistent with previous 
reports concerning old skeletal muscle with impaired re- 
growth/repair (18,47,48) in which increased myogenin 
expression has been suggested to be a compensatory 
mechanism to maintain differentiation (48). Complete 
regeneration of muscle fibres is dependent upon differ- 
entiation and fusion of myogenic cells into functional 
myofibres. Previous studies have reported similar find- 
ings of reduced differentiation and myotube formation 
in MPCs from old skeletal muscle (18,49–51), but the 
study described here is the first to associate attenuated 
differentiation with delayed exit from the cell cycle, in 
P-0 MPCs from skeletal muscle of old subjects. 
In conclusion, our findings of delayed p38 MAPK 
phosphorylation with lower MyoD and p21
Cip1 
protein 
expressions in 32-month old P-0 MPCs may posit a cau- 
sal explanation to why MPCs from old skeletal muscle 
display prolonged proliferation/delayed exit from the cell 
cycle with consequential reduced differentiation poten- 
tial. Based on our observations, a possible interpretation 
may be that at a time during muscle regeneration, when 
differentiation stimuli are abundant in the muscle, old 
MPCs (which are still in a highly proliferative state, 
compared to young), are likely to be unable to respond 
to cues that induce differentiation before these cues sub- 
side, thus, potentially impairing muscle regeneration. 
While these findings enhance our understanding of the 
intrinsic machinery within old MPCs, future research will 
be necessary to determine whether mechanisms sug- 
gested in this report play a role in in vivo models of mus- 
cle regeneration with ageing. 
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